Hernia repair market seen reaching $7.17 billion by 2035

The global hernia repair market is projected to grow from $4.78 billion in 2026 to $7.17 billion by 2035, driven by robotic surgery adoption, outpatient reimbursement expansion and rising obesity-linked demand. The report points to faster growth in robotic-assisted procedures, biologic mesh and ambulatory surgical centers as payers and providers shift more cases out of hospitals.

Why it matters: - Hernia repair demand is rising as obesity and aging populations expand the patient pool. - The market is also shifting toward higher-value devices, especially robotic-compatible mesh and biologic products. - Payer coverage changes are pushing more procedures into outpatient settings, which can lower costs and increase total procedure volume.

What happened: - Market Research Future projected the global hernia repair market to reach $7.17 billion by 2035, up from $4.78 billion in 2026. - The market was estimated at $4.57 billion in 2025. - The report pegged the forecast CAGR at 4.6% for 2026-2035. - The projection was based on demographic growth, technology adoption and reimbursement expansion.

The details: - Obesity is a major demand driver. The World Obesity Federation projects 1.5 billion adults will have a BMI above 30 by 2030. - CMS expanded ambulatory surgical center-eligible codes for complex ventral hernia repair in its 2024 Outpatient Prospective Payment System rule. - The CMS change is estimated to open 180,000 additional procedures a year to the outpatient setting. - India’s Ayushman Bharat Pradhan Mantri Jan Arogya Yojana added elective hernia repair to its coverage list in 2023. - The India coverage expansion extends cashless surgical access to more than 500 million beneficiaries. - Similar coverage growth in Brazil’s SUS system and China’s urban employee insurance programs is supporting demand. - The report said these initiatives are building procurement infrastructure and clinical demand in multiple regions. - Robotic and minimally invasive procedures are gradually replacing open surgery in many hospitals. - Hospital systems added more than 1,800 robotic surgical consoles worldwide in 2024. - Hernia repair represented about 12% of total robotic general surgery case volume. - Robotic platforms reduce conversion-to-open rates by an estimated 35% versus conventional laparoscopy. - Three new robotic surgery platforms expected between 2025 and 2028 are projected to reduce procedure costs by 15% to 20% from 2026 to 2030. - Synthetic mesh held about 90.5% of market revenue in 2025. - Biologic mesh is projected to grow at a 6.9% CAGR. - Biosynthetic hybrid scaffolds are emerging as a premium category that combines a permanent synthetic core with a resorbable biologic layer. - Hospitals were the largest end-user segment in 2025 with a 52.3% share. - Ambulatory surgical centers were the fastest-growing end-user segment at an 8.1% CAGR.

Between the lines: - The market is not growing just because more patients need surgery. It is also growing because each case is becoming more device-intensive. - Robotic adoption supports premium mesh pricing and favors manufacturers with products designed for trocar delivery and complex repairs. - Reimbursement policy is a bigger factor than in many medtech markets. When payers move procedures outpatient, the addressable market expands quickly. - The fastest growth is shifting toward products and settings that can reduce costs while preserving outcomes, which may pressure legacy open-surgery and standard synthetic mesh products. - The competitive edge is moving toward clinical evidence, robotic compatibility and outcomes data rather than price alone.

What’s next: - The report expects robotic surgery to expand further as new platforms enter the market and lower costs. - Outpatient hernia repair should keep gaining share as reimbursement policies broaden. - Biologic and hybrid mesh categories are likely to keep taking share in contaminated or potentially contaminated cases. - By the early 2030s, broader robotic access and platform competition could reduce per-procedure costs by up to 25%, according to the report. - Data-driven outcomes registries and value-based contracts are expected to become more important in reimbursement decisions. - Personalized mesh selection using digital twin tools may move from pilots toward clinical use by 2030.

The bottom line: - Hernia repair is moving from a mature surgical category to a more technology-driven, reimbursement-sensitive market with stronger growth in robotic, outpatient and premium mesh segments.